Clinical Trial

The Effect of Catheter Protector on Catheter Dwell Time and Complications

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 5, 2024 (before its estimated May 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Objective: This study aimed to determine the effect of applying the IV House Ultradressing catheter protector on the frequency of peripheral venous catheter (PVC) replacements and complications in patients with peripheral venous catheterization in an oncology clinic. Materials and Methods: The research was planned as a randomized controlled experimental study. The population of the study consisted of patients hospitalized in the oncology clinic. The sample of the study was calculated based on the data from the study by Büyükyılmaz et al. (2019), which found a significant difference in the average duration of catheter-related phlebitis in the intervention group (2.10 ± 1.55 days) compared to the control group (1.27 ± 0.45 days), with an effect size of d=0.72. As a result of the sample size calculation, 32 patients were predicted for each group. Considering that 10% of patients might drop out during the study, a total of 70 patients, with 35 in each group, were decided to be included. After the catheter is inserted, patients in the intervention group will have their catheter area protected with IV House Ultradressing, while no protective measures will be applied to the control group. Both groups will be evaluated in terms of catheter duration and PVC complications. It is planned to use t-tests and chi-square tests for data analysis.
Trial Details
NCT Number NCT06675786
Lead Sponsor Karamanoğlu Mehmetbey University
Conditions Peripheral Catheterization, Complications
Enrollment 70 participants
Start Date 2024-11-01
Primary Completion 2025-05-30 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2024-11-05